InClin is pleased to announce that Charles Du Mond, PhD, has joined InClin as the Senior Vice President of Biometrics. In this role, Dr. Du Mond will review all InClin biometrics work products and be responsible for providing therapeutic area and technical expertise with respect to the development of the protocol, data collection, and conduct of the statistical analyses.
“We are thrilled to welcome Charles as our Senior Vice President of Biometrics,” said Arnold Wong, Chief Executive Officer of InClin. “His extensive experience and passion for innovative research and development makes him a great asset to the InClin team. I have no doubt that he will provide unparalleled and invaluable service to our customers in this role.”
Dr. Du Mond has 30+ years of experience working in the biotechnology, pharmaceutical, medical device, and CRO industries, providing study design, data management, clinical pharmacokinetics, statistical analysis, regulatory support, product development plans, and data safety monitoring boards.
Prior to InClin, Dr. Du Mond started his career at Syntex Research working in HIV/AIDS, antiviral products, and infectious disease. He went on to Liposome Technology (later renamed SEQUUS) and then co-founded Pacific Research Associates (PRA), which was subsequently acquired by ICON. Dr. Du Mond most recently served as Vice President of Biometrics at Relypsa. He received his MS and PhD in Statistics from The University of Iowa. He also has a BA in English and Mathematics/Computer Science from Central College in Pella, Iowa.
About InClin
InClin is a full-service Contract Research Organization (CRO) with offices in the San Francisco Bay Area and Sydney, Australia. We are a single source provider of an integrated full suite of clinical development services from Phase 1 through Phase 4, including project management, clinical monitoring, site and contract management, vendor management, data management, biostatistics, programming, drug safety, medical monitoring, medical writing, QA inspection readiness, as well as strategic consulting services. For more information feel free visit our website or contact us at our email address below.